PubRank

Torsten Böhler

Author PubWeight™ 16.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 FTY720 (fingolimod) in renal transplantation. Clin Transplant 2006 1.09
2 Reconstitution of immunodeficient SCID/beige mice with human cells: applications in preclinical studies. Toxicology 2007 1.05
3 Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Am J Transplant 2003 1.04
4 Impact of the variability of cyclosporin A trough levels on long-term renal allograft function. Nephrol Dial Transplant 2002 0.92
5 Biomarkers as a tool for management of immunosuppression in transplant patients. Ther Drug Monit 2010 0.90
6 Therapeutic potential of targeting SK1 in human cancers. Adv Cancer Res 2013 0.90
7 FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int 2004 0.90
8 Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril. Am J Physiol Renal Physiol 2005 0.88
9 High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial Transplant 2003 0.87
10 Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer. Nat Rev Urol 2011 0.86
11 Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failure. Nephron Clin Pract 2003 0.85
12 Current perspectives on FTY720. Expert Opin Investig Drugs 2007 0.84
13 Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. Nephrol Dial Transplant 2002 0.83
14 The immunosuppressive potential of misoprostol--efficacy and variability. Clin Immunol 2003 0.79
15 Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation. Clin J Am Soc Nephrol 2009 0.78
16 FK506, transforming growth factor-beta1 and mesangial matrix synthesis: parallels and differences compared with cyclosporine A. Cytokine 2006 0.77
17 Impact of PGE1 on cyclosporine A induced up-regulation of TGF-beta1, its receptors, and related matrix production in cultured mesangial cells. Cytokine 2003 0.77
18 Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein. Artif Organs 2012 0.76
19 Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome. Int Immunopharmacol 2009 0.75
20 Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine A. Clin Immunol 2006 0.75
21 In vitro mitogen-stimulated T-cell from hepatitis C virus-positive liver transplantation candidates, increases T-cell activation markers and T-cell proliferation. Transpl Immunol 2008 0.75
22 Immunohistochemical double-staining of renal allograft tissue: critical assessment of three different protocols. Virchows Arch 2001 0.75